Precision Oncology Coverage: Malaysia’s Malayan Re and China Re Life signed a reinsurance treaty to back a new framework for cancer precision medicine, including CAR-T and targeted therapies, with overseas treatment benefits for policyholders. Ebola Response in DRC: The DRC announced free healthcare for all illnesses in Ituri as Ebola cases and deaths rise, with doubled risk allowances for doctors in the response. Hospital Accountability in UK: Nottinghamshire police arrested two men over mortuary service misconduct at Nottingham University Hospitals ahead of a major independent maternity review. Medicare Osteoporosis Test: Medicare will reimburse a new osteoporosis screening method using biomechanical CT, starting Oct. 5, 2026, with retroactive coverage to Jan. 1, 2024. Pharma M&A: AbbVie agreed to buy Apogee Therapeutics for $10.9B to expand immunology, while Sun Pharma will acquire Innovcare Lifesciences for about Rs 271.2 crore. Drug Safety: FDA recalled chlorthalidone blood pressure tablets over failed dissolution specs, citing possible ineffectiveness. Public Health & Access: Kenya’s Pharmacy and Poisons Board arrested 95 fake pharmacists and shut 48 unlicensed premises in a Nairobi-region crackdown. Clinical Pipeline Moves: Prime Medicine got FDA RMAT for PM359 in chronic granulomatous disease; Praxis Precision Medicines earned Breakthrough Therapy for elsunersen in SCN2A-related seizures. Healthcare Under Strain: UK heatwave concerns echoed by NHS A&E pressure and hospital overheating risks.